The Avandia hype: cooler heads prevail

As reported in Medscape : The US Food and Drug Administration is lifting restrictions on the prescribing and use of the diabetes drug rosiglitazone on the basis of recent data that demonstrate no elevated cardiovascular risk.

http://doctorrw.blogspot.com/2013/11/the-avandia-hype-cooler-heads-prevail.html